.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
QuintilesIMS
Teva
Queensland Health
Dow
Colorcon
Johnson and Johnson
Daiichi Sankyo
Cipla
Covington

Generated: September 24, 2017

Therapeutic Class: Skeletal Muscle Relaxants

Ingredients / Generics in Therapeutic Class: Skeletal Muscle Relaxants

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Intl
AMRIX
cyclobenzaprine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL021777-001Feb 1, 2007RXYesNo► Subscribe► SubscribeY ► Subscribe
Teva Pharms Intl
AMRIX
cyclobenzaprine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL021777-001Feb 1, 2007RXYesNo► Subscribe► Subscribe ► Subscribe
Teva Pharms Intl
AMRIX
cyclobenzaprine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL021777-001Feb 1, 2007RXYesNo► Subscribe► SubscribeY ► Subscribe
Teva Pharms Intl
AMRIX
cyclobenzaprine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL021777-001Feb 1, 2007RXYesNo► Subscribe► SubscribeY ► Subscribe
Teva Pharms Intl
AMRIX
cyclobenzaprine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL021777-001Feb 1, 2007RXYesNo► Subscribe► Subscribe ► Subscribe
Teva Pharms Intl
AMRIX
cyclobenzaprine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL021777-001Feb 1, 2007RXYesNo► Subscribe► Subscribe ► Subscribe
Teva Pharms Intl
AMRIX
cyclobenzaprine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL021777-001Feb 1, 2007RXYesNo► Subscribe► SubscribeY ► Subscribe
Teva Pharms Intl
AMRIX
cyclobenzaprine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL021777-002Feb 1, 2007RXYesYes► Subscribe► SubscribeY ► Subscribe
Teva Pharms Intl
AMRIX
cyclobenzaprine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL021777-002Feb 1, 2007RXYesYes► Subscribe► Subscribe ► Subscribe
Teva Pharms Intl
AMRIX
cyclobenzaprine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL021777-002Feb 1, 2007RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Daiichi Sankyo
Julphar
Farmers Insurance
Boehringer Ingelheim
Argus Health
Cipla
Medtronic
Fuji
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot